Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study assesses the safety and efficacy of bardoxolone methyl relative to placebo in patients with connective tissue disease-associated pulmonary arterial hypertension to determine the recommended dose range and evaluate the change from baseline in 6-minute walk distance (6MWD) following 24 weeks of study participation.
Epistemonikos ID: 2217e8ee75c93e83c4c46bac101edf16a4291a72
First added on: May 12, 2024